Jane Street Group LLC Decreases Stake in Owens & Minor, Inc. (NYSE:OMI)

Jane Street Group LLC lessened its position in Owens & Minor, Inc. (NYSE:OMI - Free Report) by 87.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 22,523 shares of the company's stock after selling 163,757 shares during the period. Jane Street Group LLC's holdings in Owens & Minor were worth $294,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Freestone Grove Partners LP purchased a new stake in shares of Owens & Minor during the 4th quarter valued at about $5,125,000. Northern Trust Corp increased its holdings in Owens & Minor by 13.7% during the fourth quarter. Northern Trust Corp now owns 968,101 shares of the company's stock valued at $12,653,000 after buying an additional 116,754 shares during the last quarter. Susquehanna Fundamental Investments LLC bought a new position in Owens & Minor in the fourth quarter worth approximately $1,443,000. Voya Investment Management LLC raised its position in Owens & Minor by 23.5% in the fourth quarter. Voya Investment Management LLC now owns 66,517 shares of the company's stock worth $869,000 after acquiring an additional 12,672 shares during the period. Finally, Price T Rowe Associates Inc. MD increased its stake in shares of Owens & Minor by 5.5% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 57,216 shares of the company's stock worth $748,000 after purchasing an additional 2,986 shares in the last quarter. Hedge funds and other institutional investors own 98.04% of the company's stock.

Owens & Minor Trading Up 15.6%

NYSE OMI traded up $1.04 during trading hours on Thursday, hitting $7.70. 2,129,789 shares of the company were exchanged, compared to its average volume of 1,525,753. Owens & Minor, Inc. has a 52 week low of $6.07 and a 52 week high of $17.78. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. The stock has a 50-day moving average price of $7.20 and a 200 day moving average price of $10.06. The stock has a market cap of $594.86 million, a PE ratio of -11.85, a price-to-earnings-growth ratio of 0.20 and a beta of 1.31.

Owens & Minor (NYSE:OMI - Get Free Report) last released its earnings results on Saturday, May 10th. The company reported $0.23 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.03. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. During the same quarter in the prior year, the business earned $0.19 earnings per share. The business's quarterly revenue was up .7% compared to the same quarter last year. Analysts forecast that Owens & Minor, Inc. will post 1.51 earnings per share for the current fiscal year.

Owens & Minor announced that its Board of Directors has initiated a share buyback program on Friday, February 28th that permits the company to buyback $100.00 million in outstanding shares. This buyback authorization permits the company to repurchase up to 13.6% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's board believes its stock is undervalued.

Insider Buying and Selling

In related news, major shareholder Coliseum Capital Management, L acquired 160,000 shares of the stock in a transaction dated Thursday, April 3rd. The stock was acquired at an average cost of $8.53 per share, for a total transaction of $1,364,800.00. Following the completion of the purchase, the insider now owns 10,784,599 shares of the company's stock, valued at approximately $91,992,629.47. This represents a 1.51% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders purchased 625,000 shares of company stock worth $4,909,150 in the last three months. 3.69% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the company. UBS Group lowered their target price on Owens & Minor from $25.00 to $13.00 and set a "buy" rating on the stock in a research report on Thursday, February 13th. JPMorgan Chase & Co. decreased their price target on Owens & Minor from $14.00 to $10.00 and set an "underweight" rating on the stock in a report on Monday, March 10th. Citigroup lowered their price objective on Owens & Minor from $13.00 to $11.00 and set a "buy" rating on the stock in a research report on Thursday, April 17th. Finally, Robert W. Baird increased their target price on Owens & Minor from $10.00 to $11.00 and gave the stock a "neutral" rating in a research report on Monday, March 3rd. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $12.50.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.